Key result
A community pharmacy-based medication reconciliation and adherence review was associated with a reduced risk of 30-day death or re-admission compared to no review (23.4% vs 23.9%; HR 0.97; P=0.02).
Why the study?
In-hospital medication review improves postdischarge outcomes, but there is little evidence supporting community pharmacy-based interventions in transitional care.
Does a postdischarge community pharmacy-based medication reconciliation and adherence review reduce the risk of death or re-admission in patients over age 66 years discharged home from an acute care hospital?
Cohort
Does a postdischarge community pharmacy-based medication reconciliation and adherence review reduce the risk of death or re-admission in patients over age 66 years discharged home from an acute care hospital?
Effect estimate: HR 0.97 (95% CI 0.95 to 1.00)
Absolute Event Rate: 23.4% vs 23.9%
p-value: p=0.02
Community pharmacy-based medication reconciliation and adherence review postdischarge is associated with a small reduction in short-term death or re-admission among older adults.
No takes yet. Share an insight, caveat, or question.
Supports postdischarge pharmacy review consideration in older adults; leaves open confirmation via randomized trials.
Lapointe‐Shaw et al. (2019) conducted a cohort in Discharged from an acute care hospital. MedsCheck (community pharmacy-based medication reconciliation and adherence review) vs. No review was evaluated on Time to death or re-admission (emergency department visit or urgent rehospitalisation) up to 30 days (HR 0.97, 95% CI 0.95 to 1.00, p=0.02). A community pharmacy-based medication reconciliation and adherence review was associated with a reduced risk of 30-day death or re-admission compared to no review (23.4% vs 23.9%; HR 0.97; P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: